Skin Flashcards
Macule:
flat, circumscribed area <5 mm • Patch: flat, circumscribed area >5mm
• Papule:
elevated lesion <5 mm
- Plaque: elevated lesion > 5 mm
* Pustule:
discrete pus-filled lesion •
Vesicle:
fluid-filled lesion <5 mm •
Bulla:
fluid-filled lesion >5 mm
Urticaria: Hives
CLINICAL FEATURES
• Erythematous, edematous, and pruritic papules and plaques (wheals)
• Individual hives last <24 hours (just a few hours), but episodes can continue for weeks
• Localized or generalized
Acute Urticaria PATHOGENESIS
Mast cell degranulation
increased dermal vascular permeability
dermal edema
• Immediate Type I (IgE) hypersensitivity rxn
• Inciting factor: medications (opiates, abx)
Acute Urticaria treatment
TREATMENT
• Antihistamines
Acute Eczema CLINICAL FEATURES
- Pruritic inflammatory erythematous papules and scaly plaques
- Can become vesicular and crusted
- over time, skin thickens due to acanthosis
- Spongiotic dermatitis on histo: epidermal edema, perivascular lymphocytic infiltrate, and mast cell degranulation
Types of Eczema
Atopic :
• Allergic contact:
• Photoeczematous:
Irritant dermatitis
Eczema
Atopic :
autoimmune related
– Genetic predisposition
– Atopic triad of asthma, allergies, and eczema – More common in childhood, outgrow as adult
Eczema
• Allergic contact:
contact exposure to an allergen
– Type IV hypersensitivity rxn: CD4+T lymphocyte mediated – Poison ivy, neosporin
Eczema
• Photoeczematous:
abnl reaction to ultraviolet light •
Eczema
Irritant dermatitis:
contact exposure to irritant
Erythema Multiforme
Hypersensitivity reaction most often due to medication/drug and certain infections
•
– Common meds: sulfonamides, PCN, NSAIDs, hydroquinone
– Infections: HSV and mycoplasma
On spectrum of Stevens Johnson (more mucosal involvement and wider surface area) and toxic epidermal necrolysis (TEN- full thickness epidermal necrosis)
Erythema Multiforme
CLINICAL FEATURES
- “targetoid” lesions
- Multiple features with macules, papules, vesicles with central pallor
- Can lead to epidermal desquamation if progresses
Chronic Inflammatory Dermatosis: PSORIASIS
• Chronic inflammatory dermatosis in
1-2% of US population
Chronic Inflammatory Dermatosis: PSORIASIS
• Associated with
heart disease and 10% can develop psoriatic arthritis
Chronic Inflammatory Dermatosis: PSORIASIS
————- mediated rxn
• Autoimmune, T-cell
Chronic Inflammatory Dermatosis: PSORIASIS
• Can be localized to
specific areas or generalized and severe (erythroderma)
Chronic Inflammatory Dermatosis: PSORIASIS
CLINICAL FEATURES
• erythematous salmon-pink colored plaques with silvery scale
– extensor elbows, knees, scalp, gluteal cleft
– nail thickening and dystrophy
• Koebner: induce lesion by local trauma
• Auspitz sign: punctate bleeding when overlying scale is removed
Psoriasis Histopathology:
• Epidermal thickening (acanthosis) with incr epidermal cell turnover but lack of maturation
– Epidermal hyperplasia
– Downward extension of rete ridges
– Parakeratotic scale
Chronic Inflammatory Dermatosis: Lichen Planus
- Pruritic
- Purple
- Polygonal
- Planar papules and plaques
- Covered in Oral Pathology
Infectious Dermatoses
Bacterial Infection • Impetigo
– ———-, can be Strep pyogenes
Staph Aureus
Infectious Dermatoses
Bacterial Infection • Impetigo
– Contagious, more commonly
in kids, spread through direct contact
Infectious Dermatoses
Bacterial Infection • Impetigo
– Starts as small
macule often perioral/perinasal
Infectious Dermatoses
Bacterial Infection • Impetigo
– Enlarges with
honey-colored crust (dried serum)
Infectious Dermatoses
Bacterial Infection • Impetigo
– Treat with
antibiotics with good Staph coverage
Blistering Dermatoses
Blistering disease where
vesicles and bullae are primary skin finding
Blisters occur at different levels within epidermis Distinguished clinically and histopathologically
– Direct immunofluorescence (DIF) can help diagnose
Blistering dermatoses
Blistering dermatoses examples
- Pemphigus Vulgaris
* Pemphigus Foliaceus • Bullous Pemphigoid
Acantholysis:
lysis of intercellular junctions between squamous cells
• Subcorneal
(superficial epidermis at stratum granulosum): pemphigus foliaceus
• Suprabasal (above basal cell):
pemphigus vulgaris
Nonacantholysis
• Subepidermal (below DEJ):
bullous pemphigoid with intact intercellular junctions
Pemphigus • Type —– hypersensitivity reaction
II
Pemphigus
• IgG autoantibodies bind to
desmoglein type I and type 3 intercellular desmosomal proteins
Pemphigus
– Disrupted intercellular adhesion causes
blistering
Pemphigus
• DIF:
intercellular IgG deposition along keratinocyte cell membranes (fish-net)
– Pemphigus vulgaris:
IgG deposits throughout epidermis
– Pemphigus foliaceus:
IgG deposits in superficial layers of
epidermis
Pemphigus Vulgaris
• Rare disease of elderly
• women>men
• Mucosal and skin involvement
– Pressure points on trunk, groin, axillae, face
– Intraoral involvement
• Flaccid blisters that easily rupture leaving denuded
skin with extensive erosions and crusting
• Treatment: immunosuppressants +/- systemic steroids
Pemphigus Vulgaris DIF:
fishnet pattern with intercellular IgG deposition around keratinocyte cell membranes throughout epidermis
Actinic Keratosis/Cheilitis
Red, rough patches on
chronically sun exposed skin (mainly head/neck, lips, dorsal hands)
Actinic Keratosis/Cheilitis
• More common in
fair-skinned and blond/red heads
Actinic Keratosis/Cheilitis
• Histo:
cytologic atypia with hyperplasia of basal cells with overall epidermal thinning
Actinic Keratosis/Cheilitis
• Can rarely evolve into
squamous cell carcinoma, particularly with TP53 mutation from UV DNA damage
Actinic Keratosis/Cheilitis
• Treatment:
cryotherapy (liquid nitrogen), topical chemotherapy agents
Squamous Cell Carcinoma
• Forms in basal layer of epidermis • 2nd most common type of skin cancer • UV light exposureDNA mutations, loss of DNA repair, leading to cell damage • TP53 mutation • HRAS and Notch receptor mutations
Squamous Cell Carcinoma-in-situ:
red scaly plaque with squamous atypia throughout epidermis
• Over time, become invasive, nodular, and ulcerate
• Men>women
• Squamous atypia through epidermis
• Invasive when penetrates through BM
SCC metastasis
- Mucosal>cutaneous
- Thickness of lesion and depth of invasion into dermis
- Size >2 cm
- Ulceration
- High risk locations such as head/neck, particularly lips, ears, around eyes
SCC Treatment
• Treatment of choice is
tumor resection
– If detected early, simple excision
– If more aggressive, can be done by Mohs surgical technique (tumor removed layer by layer, evaluated histopathologically in real time, with additional layers taken for residual tumor; repair of defect)
Basal Cell Carcinoma
• Most common type of skin cancer
• Pearly pink, translucent papules with telangiectasias; can become nodular and ulcerate
• Superficial: multifocal growth in epidermis
• Nodular: downward invasion to dermis
– Can be locally aggressive but rarely metastasizes
Basal Cell Carcinoma
Histopathology
- Arise in basal layer of epidermis
* Palisading nests of basaloid cells with hyperchromatic nuclei surrounded by fibrotic stroma
• Genetic disorder: Basal Cell Nevus Syndrome (Gorlin Syndrome) with
PTCH gene mutation in Hedgehog tumor suppressor pathway
Nodular BCC
Frequently on nasaolabial folds or above upper lip
Pearly translucent nodule with telangiectasias
Melanocytic Nevi (Moles) • benign neoplasm of melanocytes
Congenital or acquired
• BRAF mutation as common factor in nevi
• Cellular senescence: migration of nevi from DEJ into dermis
– Superficial nevi: produce melanin, grow in nests
– Deeper nevi: minimal to no pigment, grow in cords or single cells
Growth pattern of Nevi
• Junctional
– Nests at dermal-epidermal junction
Growth pattern of Nevi
• Compound
– Nests at DEJ and dermis
Growth pattern of Nevi
• Intradermal +/- cellular senescence
– Nests primarily dermal (intradermal)
Dysplastic Nevi
• Marker for melanoma, not precursor
• Vast majority will not transform into melanoma • BRAF mutation common, NRAS mutation
• Size>5mminsize
• Pigment variegation
• Border irregularity
• Familial Dysplastic Nevus Syndrome
– Dysplastic nevi >100s with strong melanoma risk • Cytologic atypia of melanocytes on histopath
Melanoma
- Skin cancer derived from melanocytes
- 3rd most common type of skin cancer after BCC and SCCs, but can be highly aggressive and more likely to metastasize if untreated
- Early detection critical and can be curative
- Delayed detection can lead to metastasis and poor prognosis
Clinical Signs of Melanoma
- Rapid change in size of prior nevus with asymmetry
- Color change and/or variability
- Itching/pain associated in a lesion
- New onset pigmented lesion esp in adults
- Irregular borders
Melanoma
ABCDEs
(Asymmetry, Border irregularity, Color change, Diameter, Evolution)
• Vertical growth phase is the key factor in nature of
melanomas
Melanoma Histopathology
- Melanocytes are irregular in size and shape with prominent nucleoli
- Radial and vertical growth seen histologically
- Atypical mitoses common
- Specific special stains, such as HMB-45, can help detect melanocytes
Risk Factors for Metastasis
• Depth of invasion (Breslow thickness in mm) – In-situ: intraepithelial
– Dermal/Invasive: through epidermis into dermis
• Tumor Size
• Ulceration
• Mitoses
• Lymph node involvement